ANDRX PHARMACEUTICALS LLC has a total of 33 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, chemical engineering and packaging and shipping are CHUNG YIH-LIN, MC2 THERAPEUTICS LTD and AF CHEMICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Canada | 6 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 3 | |
#6 | Australia | 2 | |
#7 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Chemical engineering | |
#3 | Packaging and shipping | |
#4 | Machine tools | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Nangia Avinash | 21 |
#2 | Li Boyong | 10 |
#3 | Browder Monte | 9 |
#4 | Cheng Xiu Xiu | 8 |
#5 | Dixit Manesh | 5 |
#6 | Chen Chih-Ming | 5 |
#7 | Chen Chih Ming | 4 |
#8 | Xie Jianbo | 4 |
#9 | Zhang Guohua | 4 |
#10 | Carter Roger | 4 |
Publication | Filing date | Title |
---|---|---|
US2008044467A1 | Formulation and process for drug loaded cores | |
US2005163847A1 | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug | |
CN1863517A | Rapidly disintegrating formulation | |
WO2004112711A2 | Oral extended-release composition | |
AU2003297589A1 | Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties | |
US7470435B2 | Extended release venlafaxine formulation | |
US6966453B2 | Apparatus and method for regulating the delivery of bulk tablets to a tablet transport system | |
US6756564B2 | System and method for removing particulate created from a drilled or cut surface | |
US7029701B2 | Composition for the treatment and prevention of ischemic events |